Joann A Reed
CIK 1252013 · SVP, Finance and CFO · last filed 2025-05-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MHS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
116 HUNTINGTON AVENUE
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMT | Director | 62,940 | $184.82 | $11.63M | -$3.41M | 28 | 2025-05-16 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 0 | $0.34 | $0 | $17.5K | 14 | 2022-03-21 |
| WAT | Director | 39,685 | $466.10 | $18.50M | -$4.46M | 21 | 2021-03-08 |
| HEALTH MANAGEMENT ASSOCIATES, INC (HMA) Delisted | Director | — | $10.54 | — | $0 | 3 | 2014-01-27 |
| DynaVox Inc. (DVOX) Delisted | Director | 13,336 | — | — | $0 | 2 | 2012-06-04 |
| MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | SVP, Finance and CFO | 167,818 | — | — | -$10.55M | 3 | 2007-09-05 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| MHS | Direct | 167,130 | 99.6% | 2007-09-05 |
| By 401(k) | 688 | 0.4% | 2007-09-05 | |
| Total | 167,818 |
Recent Filings · Page 4 of 8
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-11-13 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +1,000 | $21.5K | EDGAR |
| 2017-10-03 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −476 | -$17.8K | EDGAR |
| 2017-05-05 | AMT | Mixed | +17,600 | $69.7K | EDGAR |
| 2017-03-14 | AMT | Grant (A) | +1,321 | $0 | EDGAR |
| 2017-03-03 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +3,437 | -$117.8K | EDGAR |
| 2017-01-05 | WAT | Grant (A) | +806 | $0 | EDGAR |
| 2017-01-05 | WAT | Grant (A) | +843 | $0 | EDGAR |
| 2016-10-04 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +1,057 | $0 | EDGAR |
| 2016-07-25 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +1,037 | $0 | EDGAR |
| 2016-03-18 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +3,583 | -$25.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).